Understanding Antimalarials in Lupus Treatment

Patients frequently ask why medications originally designed to treat malaria are effective for autoimmune diseases. We find the answer by examining how the immune system functions. A central activity of the immune system is antigen presentation – substances that cause our immune system to create protective antibodies are known as antigens. Antimalarials in lupus can help where this process goes wrong.

---

NOTE: Johns Hopkins University Press, publisher of The Lupus Encyclopedia, is a nonprofit publisher. If you purchase JHUP books, like The Lupus Encyclopedia, you support projects like Project MUSE.

---

For example, when a virus enters the body, the immune system identifies these foreign antigens. It then launches a defense by producing specific antibodies. Our immune system remembers these invaders. Therefore, we are less likely to get sick from the same virus again. However, in systemic lupus erythematosus (SLE), this process goes awry. The immune system mistakenly attacks natural substances within our own bodies, treating them as dangerous foreign antigens.

The Role of Antigen Processing

To understand how antimalarials work, we must look at antigen processing. Frontline white blood cells, such as macrophages, identify unusual substances. They engulf these materials inside tiny bubbles called vacuoles. As the Lupus Encyclopedia explains, “The vacuoles digest these antigens into smaller components, reassemble them, then attach these reassembled structures to their outer surface.”

These cells then present the digested antigens to T-cells. In lupus, the T-cells wrongly identify normal body substances as threats. Consequently, they instruct B-cells to produce autoantibodies. These autoantibodies attack our own tissues. This process leads to inflammation and damage throughout the body.

How Antimalarials Calm the Immune System

Antimalarials interfere with this abnormal antigen processing. For antigen presentation to occur successfully, the vacuoles inside the cells must remain highly acidic. Medications like hydroxychloroquine concentrate inside these vacuoles. They raise the pH levels, making the environment less acidic.

Because of this change, digesting enzymes cannot break down the antigens. The Lupus Encyclopedia states, “The T-cells cannot ‘see’ these antigens and, thus, do not signal B-cells to make lupus autoantibodies.” Therefore, antimalarials effectively calm down the overactive immune system.

Importantly, these medications are not true immunosuppressants. Our immune system continues to function normally in other areas. We still retain protection against common infections and illnesses. The text clarifies, “We call HCQ an immunomodulator and not an immunosuppressant. It calms down the immune system (or modulates it) without suppressing it.”

The Extensive Benefits of Hydroxychloroquine

Rheumatologists often refer to hydroxychloroquine (HCQ) as life insurance for lupus patients. It remains the only medication proven by large research studies to prolong life expectancy in SLE. We always seek effective therapies that minimize side effects. HCQ perfectly fits this description.

Reducing Flares and Organ Damage

Antimalarials significantly decrease the frequency and severity of lupus flares. Studies indicate that patients taking an antimalarial experience fewer flares. Moreover, their flares are generally milder compared to those not taking the medication.

Regular use also helps prevent long-term damage to vital organs. Lupus damage occurs in two stages. First, inflammation attacks an organ. Second, healing leaves permanent scar tissue. By reducing inflammation quickly, antimalarials prevent this permanent scarring. We aim to control the disease before it causes irreversible harm. The source confirms, “Regular HCQ usage reduces long-term organ damage.”

Protecting Cardiovascular Health

People with lupus face an increased risk of blood clots, heart attacks, and strokes. Many patients possess antiphospholipid antibodies, which contribute to these risks. Taking HCQ regularly lowers the chances of developing dangerous blood clots.

Furthermore, these medications help lower total cholesterol and bad cholesterol levels. Research shows that patients using HCQ are less likely to develop diabetes, another significant risk factor for heart disease. By managing these factors, antimalarials offer crucial cardiovascular protection.

The Role of Chloroquine in Treatment

While hydroxychloroquine remains the most common choice, we sometimes utilize chloroquine (CQ) as an alternative. Chloroquine often works faster. While HCQ can take several months to reach full efficacy, CQ generally achieves its full effect within two to three months.

Therefore, rheumatologists might prescribe CQ for severe skin lupus flares that require a more rapid response. The dosing for chloroquine also depends heavily on actual body weight. Patients should take no more than 2.3 mg per kilogram of body weight daily. Similar to HCQ, regular monitoring and strict adherence to recommended eye screening schedules are vital when taking chloroquine.

Navigating Potential Side Effects

While antimalarials offer numerous benefits, we must monitor for potential side effects. Most patients tolerate these medications very well. Nuisance side effects, such as mild stomach upset or headaches, usually resolve by adjusting the dose or taking the pill with food.

Understanding Eye Care Requirements

The most significant concern regarding antimalarials is potential damage to the retina. The retina captures light and allows us to see. Over many years, these drugs can sometimes accumulate in the retina. This condition is known as antimalarial retinopathy.

If left unchecked, retinopathy causes blurred vision and light intolerance. However, modern screening techniques have made these medications incredibly safe. The Lupus Encyclopedia reassures readers, “Do not let the very small chances of antimalarials affecting your eyes scare you. Most people taking them never develop retinopathy.”

Crucial Eye Screening Tests

To ensure safety, patients must undergo specific eye examinations. We recommend a baseline retinal exam shortly after starting the medication. Following this, annual exams usually begin after five years of treatment.

These evaluations must include advanced testing. Your eye doctor should perform a spectral-domain optical coherence tomography (SD-OCT) and a visual field 10-2 test. These highly sensitive tools detect microscopic changes long before any vision loss occurs. The text emphasizes, “When the eye testing outlined above is followed closely, your eye doctor can detect problems before you would ever notice any visual changes.”

Patients can also monitor their vision at home using an Amsler grid. This simple tool helps identify early signs of visual distortion. While it does not replace professional exams, it offers valuable peace of mind between appointments.

Proper Dosing and Monitoring

Correct dosing balances effectiveness with safety. Recommendations for maximum daily doses depend on actual body weight. For instance, current guidelines suggest taking no more than 5 mg of hydroxychloroquine per kilogram of body weight daily.

We now have the ability to measure hydroxychloroquine levels in the blood. This blood test helps rheumatologists fine-tune the dosage. We aim for a specific target range to ensure optimal disease control while minimizing the risk of side effects. Measuring blood levels provides concrete evidence of how well the body absorbs and utilizes the medication.

Everyone diagnosed with lupus should take an antimalarial unless they have a genuine allergy. The profound advantages far outweigh the minimal risks. By carefully managing the dosage and attending regular screenings, we can harness the protective power of these medications safely. For further information and support, we encourage exploring resources provided by organizations like More Than Lupus and Kaleidoscope Fighting Lupus. You can also find comprehensive information regarding treatments by visiting our medication resources page on the main site. The Lupus Encyclopedia notes that for both medications, “If you take the proper precautions, vision problems from antimalarials should not occur.”

For more in-depth information on Understanding Antimalarials in Lupus Treatment:

Read more in The Lupus Encyclopedia, edition 2

Look up your symptoms, conditions, and medications in the Index of The Lupus Encyclopedia

If you enjoy the information from The Lupus Encyclopedia, please click the “SUPPORT” button at the top of the page to learn how you can help. 

---

What are your comments and opinions?

If you have lupus, what has your experience been? What do you recommend for other patients?

Do you have any questions to ask Dr. Thomas?

Please click on “Leave a Comment” above to comment.

Please support “The Lupus Encyclopedia” blog post page

Click on “SUPPORT” at the top of the page to learn how you can support “The Lupus Encyclopedia“

FAQs

This article includes contributions from